Share ownership AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 16:35:18 09/06/2026 BST			5-day change	1st Jan Change
13,632.00 ^GBX	-1.19%		+3.16%	-1.15%

06-09	Stockholm stocks retreat on Tuesday, OMXS30 index sheds 1.2 percent	FW
06-09	What Bundibugyo Ebola vaccines and treatments are under development	RE

Share class: AstraZeneca PLC

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,551,009,750	1,498,713,447 ( 96.63 %)	0	96.63 %

Major shareholders: AstraZeneca PLC

Name	Stocks	%	Valuation
Vanguard Capital Management LLC 5.027 %	77,965,099	5.027 %	14 505 M p
Wellington Management Co. LLP 4.199 %	65,120,892	4.199 %	12 115 M p
Capital Research & Management Co. (World Investors) 4.052 %	62,839,170	4.052 %	11 691 M p
Investor AB (Investment Company) 3.326 %	51,587,810	3.326 %	9 598 M p
BlackRock Investment Management (UK) Ltd. 3.092 %	47,954,078	3.092 %	8 922 M p
Vanguard Capital Management LLC 2.904 %	45,040,142	2.904 %	8 379 M p
Capital Research & Management Co. (International Investors) 2.217 %	34,393,013	2.217 %	6 399 M p
Vanguard Fiduciary Trust Co. 2.123 %	32,925,791	2.123 %	6 126 M p
Norges Bank Investment Management 2.085 %	32,331,000	2.085 %	6 015 M p
Fidelity Management & Research Co. LLC 1.908 %	29,598,097	1.908 %	5 507 M p
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Stocks	%	Valuation
Caixa DTVM SA 0.001036 %	96,462	0.001036 %	3 M p

Breakdown by shareholder type

Institutional	94.08%
Others	5.2%
Schweizerische Nationalbank	0.4%
Governments	0.4%
Manulife Financial Corp.	0.25%
Swedbank AB	0.16%
ABN AMRO Bank NV	0.16%
Intesa Sanpaolo SpA	0.07%
SEI Investments Co.	0.04%
Zurich Insurance Group AG	0.04%
Individuals	0.04%
State Street Corp.	0.02%
Migdal Insurance & Financial Holdings Ltd.	0.02%
Svenska Handelsbanken AB	0.01%
Skandinaviska Enskilda Banken AB	0.01%
Wärtsilä Oyj Abp	0.01%
Phoenix Financial Ltd.	0.01%
Avolta AG	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
Principal Financial Group, Inc.	0.01%
Cullen/Frost Bankers, Inc.	0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	54.75%
United Kingdom	22.55%
Sweden	5.33%
Canada	2.9%
France	2.87%
Norway	2.22%
Switzerland	2.12%
Germany	2.04%
Luxembourg	1.22%
Netherlands	1.01%
Japan	0.67%
Singapore	0.46%
South Korea	0.37%
Bahamas	0.34%
Italy	0.31%
Spain	0.22%
Hong Kong	0.18%
Denmark	0.16%
Ireland	0.15%
Australia	0.15%
Finland	0.14%
Liechtenstein	0.13%
Belgium	0.12%
Austria	0.07%
Bermuda	0.06%
Taiwan	0.05%
South Africa	0.05%
Kazakhstan	0.04%
Individuals	0.04%
New Zealand	0.04%
Czech Republic	0.04%
Israel	0.03%
United Arab Emirates	0.02%
Thailand	0.02%
Malaysia	0.02%
Slovenia	0.01%
China	0.01%
Mexico	0.01%
Brazil	0.01%
Cyprus	0.01%
Kuwait	0.01%

Based on 1000 largest holdings

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).

Employees

96,100

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company